Savant Capital LLC boosted its stake in Clorox Company (The) (NYSE:CLX) by 3.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,801 shares of the company’s stock after buying an additional 60 shares during the period. Savant Capital LLC’s holdings in Clorox Company (The) were worth $243,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the company. Independent Advisor Alliance raised its position in Clorox Company (The) by 0.5% in the first quarter. Independent Advisor Alliance now owns 14,415 shares of the company’s stock valued at $1,936,000 after buying an additional 74 shares during the last quarter. Guyasuta Investment Advisors Inc. purchased a new position in Clorox Company (The) during the first quarter valued at about $208,000. Bronfman E.L. Rothschild L.P. raised its position in Clorox Company (The) by 12.1% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,100 shares of the company’s stock valued at $283,000 after buying an additional 227 shares during the last quarter. Oxford Asset Management purchased a new position in Clorox Company (The) during the first quarter valued at about $1,846,000. Finally, First National Trust Co. purchased a new position in Clorox Company (The) during the first quarter valued at about $1,002,000. 71.58% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Shares of Clorox Company (NYSE CLX) opened at 139.50 on Friday. The firm has a market cap of $17.97 billion, a price-to-earnings ratio of 27.56 and a beta of 0.41. Clorox Company has a 12 month low of $111.24 and a 12 month high of $140.55. The stock’s 50 day moving average price is $134.35 and its 200 day moving average price is $129.41.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Wednesday, May 3rd. The company reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.01. Clorox Company (The) had a return on equity of 215.99% and a net margin of 11.22%. The business had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the previous year, the firm posted $1.21 earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. Equities research analysts predict that Clorox Company will post $5.31 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 4th. Investors of record on Wednesday, July 19th will be paid a $0.84 dividend. This is a boost from Clorox Company (The)’s previous quarterly dividend of $0.80. This represents a $3.36 annualized dividend and a dividend yield of 2.41%. Clorox Company (The)’s payout ratio is 63.12%.

WARNING: This report was first reported by Financial Market News and is owned by of Financial Market News. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.financial-market-news.com/2017/06/17/savant-capital-llc-increases-stake-in-clorox-company-the-clx.html.

Several equities analysts recently issued reports on the company. BMO Capital Markets reissued a “buy” rating and set a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Jefferies Group LLC set a $138.00 price target on Clorox Company (The) and gave the company a “hold” rating in a research report on Wednesday, May 3rd. Royal Bank Of Canada set a $115.00 price target on Clorox Company (The) and gave the company a “hold” rating in a research report on Monday, April 24th. Vetr raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price target on the stock in a research report on Monday, April 24th. Finally, Citigroup Inc. increased their price target on Clorox Company (The) from $75.00 to $76.00 and gave the company a “neutral” rating in a research report on Friday, April 7th. Eleven research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Clorox Company (The) currently has a consensus rating of “Hold” and an average price target of $128.97.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.